SEC CIK 734383 · Series S000002922 · Portfolio as of 2026-04-30
| Security | Value | Weight |
|---|---|---|
| Eli Lilly & Co · LLY | $3.35B | 9.11% |
| Merck & Co Inc · MRK | $2.00B | 5.43% |
| AstraZeneca PLC · AZN | $1.88B | 5.11% |
| UnitedHealth Group Inc · UNH | $1.44B | 3.93% |
| Johnson & Johnson · JNJ | $1.27B | 3.46% |
| Edwards Lifesciences Corp · EW | $1.18B | 3.22% |
| GSK PLC · GLAXF | $1.15B | 3.14% |
| Intuitive Surgical Inc · ISRG | $1.00B | 2.72% |
| Boston Scientific Corp · BSX | $868.2M | 2.36% |
| Danaher Corp · DHR | $865.5M | 2.35% |
From N-PORT Part B, units verified by net-asset reconciliation.
curl "https://api.fundlens.io/v1/funds/VGHCX/holdings" \
-H "x-api-key: your_api_key"Full holdings, every historical snapshot, point-in-time queries, monthly returns and flows — free tier available, no card required.
Source: SEC EDGAR Form N-PORT. Data is quarterly with a regulatory filing lag; this page shows the most recent public filing. Not investment advice.